Test Price
4,000 AED✅ Home Collection Available
Infliximab Antibody Test in UAE | DHA-Approved | DNA Labs UAE
Executive Summary & Core Metrics
ISO 9001:2015 accredited processing with Enzyme-Linked Immunosorbent Assay (ELISA) methodology, ensuring clinically actionable results for therapeutic drug monitoring.
VIP mobile phlebotomy with ISO-certified refrigerated transport; sample integrity guaranteed from 8 AM to 11 PM daily.
Telephonic post-test interpretation by DHA-licensed physicians. Direct billing verification via WhatsApp +971 54 548 8731.
Full adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The Infliximab Antibody Test detects neutralizing and non-neutralizing antibodies against infliximab, a TNF-alpha inhibitor biologic therapy prescribed primarily for Crohn's disease and ulcerative colitis. This quantitative ELISA is critical for identifying antibody-mediated loss of response, enabling your gastroenterologist to optimize therapeutic dosing or transition to an alternative biologic agent.
| Feature | Our Test (DHA-Approved) | Standard Alternative |
|---|---|---|
| Methodology | ELISA with enhanced sensitivity and specificity for drug-tolerant antibody detection | Routine ELISA (variable precision, potential drug interference) |
| Turnaround Time | Report within 2–3 weeks (batch processed by 7th of each month) | Often 4–6 weeks |
| Sample Handling | Refrigerated or frozen cold chain with professional phlebotomy | Standard transport, elevated risk of sample degradation |
| Price | 4,000 AED (insurance direct billing available) | Varies; often not covered by standard plans |
Physician Insight & Safety Protocols
“As a General Practitioner, I regularly counsel patients on biologic therapies who experience changes in their condition. The infliximab antibody test provides objective data to determine whether treatment failure stems from neutralizing antibodies or other pharmacokinetic factors. This information helps your specialist make informed decisions about continuing, dose-escalating, or switching therapy. It is essential never to discontinue or alter your medication without consulting your treating physician.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
⚠ Medication Warning
Do not discontinue or adjust prescribed immunosuppressants or biologic therapies without consulting your treating gastroenterologist or rheumatologist. Abrupt cessation can trigger severe disease flares or infusion reactions. All clinical decisions must comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. If you experience symptoms of a serious infusion reaction—such as difficulty breathing, chest tightness, or facial swelling—seek emergency medical care immediately.
Exclusion Criteria and Emergency Red Flags
- Recent (within 48 hours) intake of biotin, vitamin B7, or multivitamins – sample will be rejected due to assay interference.
- Incomplete Test Send Out Consent Form (Form 35) – mandatory for processing.
- Hemolyzed, lipemic, or improperly stored serum sample will be rejected for analysis.
- Seek emergency care immediately if you experience: severe shortness of breath, chest pain, facial swelling, or anaphylaxis during or after infliximab infusion.
Patient FAQ & Clinical Guidance
1. What is the infliximab antibody test and why is it necessary if my IBD is in remission?
Detecting antibodies early can prevent sudden loss of clinical response and avoid unnecessary dose escalations or infusion reactions. Routine therapeutic drug monitoring helps maintain long-term treatment effectiveness and mucosal healing.
2. How should I prepare for this test, and can I take my usual supplements?
Stop all biotin- or vitamin B7-containing supplements 48 hours before the blood draw to avoid false-negative results. Continue all prescribed medications—including infliximab—unless your doctor advises otherwise.
3. What does a positive infliximab antibody result mean for my treatment plan?
A positive result suggests that your immune system is producing neutralizing antibodies against infliximab, often requiring a switch to another biologic agent with a different mechanism of action. Your gastroenterologist will interpret the result in the context of your disease activity, drug trough levels, and prior therapy history.
4. Is the infliximab antibody test covered by my medical insurance in Dubai?
Coverage varies by plan. DNA Labs UAE offers direct billing verification for most major insurers. Contact us on WhatsApp at +971 54 548 8731 to check your eligibility and obtain a pre-authorization code before the test.
5. How soon will I receive my results, and how are they delivered?
Results are typically reported within 2–3 weeks. You will receive a secure digital copy via encrypted email or WhatsApp, along with a telephonic consultation from a DHA-licensed physician to explain the clinical implications and coordinate next steps with your specialist.
UAE Regulatory & Data Privacy Adherence
Your data and safety are protected under UAE Federal Law.
- Data Protection: All personal and medical data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Information Governance: Our digital health infrastructure adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Clinical Liability: All procedures and medical advice are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Facility Oversight: This test and all associated services are performed at a DHA-licensed facility (License No. 1143) under the supervision of Dr. Ajay Singh (DHA Registration ID: 36234132).
Clinical & Logistical Metadata
| Test Name | Infliximab Antibody Test |
| Price (AED) | 4,000 AED |
| Turnaround Time | 2–3 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (Serum) |
| Methodology Used | Enzyme-Linked Immunosorbent Assay (ELISA) |
| ICD-10-CM Code | Z79.899 |
| LOINC Code | 90862-2 |
| DHA Facility License & Laboratory Address | License: 1143 | Corporate Lab: DNA Labs UAE | Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians